775 Stock Overview
An investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 2/6 |
CK Life Sciences Int'l., (Holdings) Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.46 |
| 52 Week High | HK$0.83 |
| 52 Week Low | HK$0.46 |
| Beta | 0.27 |
| 11 Month Change | -11.54% |
| 3 Month Change | -24.59% |
| 1 Year Change | -44.58% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -24.59% |
Recent News & Updates
Recent updates
Shareholder Returns
| 775 | HK Biotechs | HK Market | |
|---|---|---|---|
| 7D | -16.4% | -4.5% | -1.6% |
| 1Y | -44.6% | -34.6% | -2.8% |
Return vs Industry: 775 underperformed the Hong Kong Biotechs industry which returned -42.3% over the past year.
Return vs Market: 775 underperformed the Hong Kong Market which returned -15.9% over the past year.
Price Volatility
| 775 volatility | |
|---|---|
| 775 Average Weekly Movement | 5.7% |
| Biotechs Industry Average Movement | 8.0% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in HK Market | 14.4% |
| 10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 775's share price has been volatile over the past 3 months.
Volatility Over Time: 775's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 1,887 | Alan Abel Yu | www.ck-lifesciences.com |
CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; licensing of registration activities and the importation of finished agricultural goods; holding of land and buildings; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products.
CK Life Sciences Int'l., (Holdings) Inc. Fundamentals Summary
| 775 fundamental statistics | |
|---|---|
| Market cap | HK$4.42b |
| Earnings (TTM) | HK$103.76m |
| Revenue (TTM) | HK$5.31b |
39.8x
P/E Ratio0.8x
P/S RatioIs 775 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 775 income statement (TTM) | |
|---|---|
| Revenue | HK$5.31b |
| Cost of Revenue | HK$3.67b |
| Gross Profit | HK$1.64b |
| Other Expenses | HK$1.54b |
| Earnings | HK$103.76m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Mar 19, 2024
| Earnings per share (EPS) | 0.011 |
| Gross Margin | 30.93% |
| Net Profit Margin | 1.95% |
| Debt/Equity Ratio | 130.1% |
How did 775 perform over the long term?
See historical performance and comparison